Pendulum Therapeutics Stock

pendulum.coBioTechFounded: 2012Funding to Date: $112.76MM

Pendulum is a biotechnology company committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases.

Register for Details

For more details on financing and valuation for Pendulum Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Pendulum Therapeutics.

Register Today

Team

Management Team

Colleen Cutcliffe Ph.D
Chief Executive Officer, Board Member & Co-Founder
Mohan Iyer
Chief Operating Officer
James Bullard Ph.D
Co-Founder, Chief Technology Officer & Secretary
John Eid Ph.D
Chief Scientific Officer, Board Member & Co-Founder
Matthew Murphy JD
General Counsel
Orville Kolterman
Chief Medical Officer

Board Members

Adam D'Augelli
True Ventures
Colleen Cutcliffe Ph.D
Hugh Martin
John Eid Ph.D
Peter Hutt JD
Roelof Botha
Sequoia Capital

Other companies like Pendulum Therapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$3.1B
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.2B
Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$1.61B

News

Whole Biome has pulled in $35 million in Series B financing from a list of investing titans, including Sequoia, Khosla, True Ventures, the Mayo Foundation and AME Ventues — just to name a few. The goal? To heal what ails you using microscopic bugs. Medical science has caught on in the last fe…
Whole Biome, a San Francisco, CA-based evidence-based microbiome company, secured $35m in Series B financing. The round brings total funding to $57m